Location History:
- San Francisco, CA (US) (1989 - 1998)
- Brookline, MA (US) (1995 - 1998)
Company Filing History:
6 out of 55 
5 out of 130 
4 out of 6 Years Active: 1989-1998
Title: **David E. Goodman: Innovator in Aerosol Medication Delivery**
Introduction
David E. Goodman is a prominent inventor based in San Francisco, CA, known for his contributions to the field of aerosol medication delivery. With an impressive portfolio of 16 patents, Goodman stands out as a significant figure in the development of technologies aimed at improving patient care and medication administration.
Latest Patents
One of Goodman’s latest patents focuses on the delivery of aerosol medications for inspiration. This innovative apparatus and its associated methods allow patients to receive an amount of aerosolized medicine in response to specific delivery points detected in their breath flow. The device enables the administration of the aerosol medication in pulses, optimizing factors such as pulse width, shape, and frequency to enhance the respirable fraction of the compound. It is designed to adapt to changes in the patient’s breath flow patterns, ensuring tailored medication delivery according to their condition. Furthermore, the device includes a library of protocols for different medications, which can be customized based on the identified contents of the medication canister.
Career Highlights
Throughout his career, Goodman has worked with notable companies, including Nellcor Incorporated and Aradigm Corporation. His experience in these organizations has played a crucial role in shaping his innovative approaches toward medical device technology.
Collaborations
Goodman has collaborated with several respected professionals in his field, including Reid M. Rubsamen and James E. Corenman. These partnerships have contributed to the success and advancement of the projects they undertook together, particularly in improving therapeutic technologies for patient care.
Conclusion
David E. Goodman exemplifies the qualities of an inventive mind, with a focus on transforming healthcare delivery through innovation in aerosol medication systems. His extensive patent portfolio and collaborative efforts mark him as a significant contributor to the medical device industry, paving the way for future advancements that can greatly benefit patients.